(RTTNews) - Exicure, Inc. (XCUR) skyrocketed 41.37%, adding $2.18 to trade at $7.45, after the company announced positive topline results from its Phase 2 study of burixafor in multiple myeloma. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback